• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

new derm national sales director













Not gonna help. We are going to take your lunch money with Stelara and Celgene will pick up the scraps with their product when we are done. The days of black box products winning are over.